机译:Bevacizumab通过从VEGF信号传导激活TG FPI途径来促进人脐静脉内皮细胞的活性生物学行为
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Radiotherapy Lanzhou University Second Hospital Lanzhou 100040 China;
Department of Oncology The First Affiliated Hospital of Hainan Medical University Haikou 570102 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
HUVEC; CD 105; bevacizumab; anlotinib; TGFβ;